P702-0210 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-3-(3-ethyl-1,2,4-oxadiazol-5-yl)-7-methyl-1,8-naphthyridin-4-amine

P702-0210 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-3-(3-ethyl-1,2,4-oxadiazol-5-yl)-7-methyl-1,8-naphthyridin-4-amine
P702-0210 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-3-(3-ethyl-1,2,4-oxadiazol-5-yl)-7-methyl-1,8-naphthyridin-4-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound P702-0210
N-(2H-1,3-benzodioxol-5-yl)-3-(3-ethyl-1,2,4-oxadiazol-5-yl)-7-methyl-1,8-naphthyridin-4-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P702-0210

Molecular Formula

C20H17N5O3 (C20 H17 N5 O3)

Compound Name

N-(2H-1,3-benzodioxol-5-yl)-3-(3-ethyl-1,2,4-oxadiazol-5-yl)-7-methyl-1,8-naphthyridin-4-amine

IUPAC name

N-(2H-13-benzodioxol-5-yl)-3-(3-ethyl-124-oxadiazol-5-yl)-7-methyl-18-naphthyridin-4-amine

SMILES

CCc1noc(-c(cnc2nc(C)ccc22)c2Nc(cc2)cc3c2OCO3)n1

InChI

InChI=1S/C20H17N5O3/c1-3-17-24-20(28-25-17)14-9-21-19-13(6-4-11(2)22-19)18(14)23-12-5-7-15-16(8-12)27-10-26-15/h4-9H,3,10H2,1-2H3,(H,21,22,23)

InChI Key

RYADRYIHHKOOJP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27612709

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

375.39

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.907

Distribution Coefficient, logD

3.744

Water Solubility, LogSw

-3.90

Polar Surface Area

76.139

Acid Dissociation Constant (pKa)

19.36

Base Dissociation Constant (pKb)

7.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

P702-0210 in Drug Discovery

Included in Screening Libraries

BRD4 Targeted Library (4534 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Others
  • Kinases

References: we are preparing a list of scientific research reports with P702-0210 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P702-0210?
Check Price and Availability of P702-0210, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P702-0210 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P702-0210
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P702-0210
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P702-0210 available by request